«Quality of Life in Patients with Metastatic or Unresectable Melanoma: Is Monotherapy with Nivolumab Preferred Over Combination Therapy?» (2024) Revista Médica de Trujillo, 19(3), pp. 092–097. doi:10.17268/rmt.2024.v19i3.6141.